Lataa...
Severe cholestasis due to adalimumab in a Crohn’s disease patient
Elevation of liver biochemistry has been reported with anti-tumor necrosis factor agents, but overt liver failure rarely reported. Autoimmune hepatitis has been more commonly reported with infliximab than adalimumab (ADA). Our case, however, describes the first reported case of ADA-associated severe...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Co., Limited
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3812463/ https://ncbi.nlm.nih.gov/pubmed/24179620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v5.i10.592 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|